Study of the Variations of Albumin Level for Patients With Unresecable Stage IIIc or Stage IV Melanoma Treated by Anti BRAF and Anti MEK
Clinical trial NCT03553329 · COMPLETED
Trial details
- NCT number
- NCT03553329
- Sponsor
- Poitiers University Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-06-02
- Primary completion
- 2018-06-02
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.